Marguerite Ann Germain, M.D.

0 0 0

Education:

1993

University of Maryland School of Medicine, Baltimore, MD Doctor of Medicine

1989

University of Maryland, Catonsville, MD B.A., Biological Sciences (summa cum laude)

Post graduate training

2000

Residency, Dermatology
National Capital Consortium (National Naval Medical Center, Bethesda, MD and Walter Reed Army Medical Center, Washington, DC)

1995

Navy Flight Surgery
Naval Aerospace and Operational Medical Institute, Pensacola, FL

1994

Internship, Internal Medicine
National Naval Medical Center, Bethesda, MD

Employment

March, 2003-Present

Private Practice, Germain Dermatology Associates, PA
Mt. Pleasant, SC

April, 2004 - 2009

Attending Physician, Department of Dermatology, Medical University of South Carolina (MUSC)

October, 2002 - February, 2003

Staff Dermatologist
Naval Hospital, Charleston, SC (civilian contract)

July, 2000 - October, 2002

Head, Department of Dermatology
Naval Hospital, Charleston, SC

July 1995 - June 1997

Flight Surgeon
Naval Air Station, Dallas, TX

June 1994 - January 1995

General Medical Officer
National Naval Medical Center, Dept. of Military Medicine, Bethesda, MD

National training center:

Allergan (fillers and BOTOX®), Zeltiq (CoolScultpting®), Merz (Ultherapy®), and Kythera (Kybella®)

Consultant and speakers bureau:

Allergan, Amgen, Merz, Galderma, Kythera

Professional organizations:

Fellow, American Academy of Dermatology

Fellow, American Academy of Anti-Aging, Regenerative, and Functional Medicine

Fellow, American Society for Mohs Surgery

Women's Dermatological Society

American Society for Dermatologic Surgery

South Carolina Medical Association

American Society of Cosmetic Dermatology and Aesthetic Surgery

American Society for Laser Medicine and Surgery

Society of Navy Flight Surgeons

Professional involvement

Jan, 2010-2015

South Beach Symposium

June, 2010, 2011

Cosmetic BootCamp, Colorado Springs, CO Faculty and nationally recognized speaker

June, 2010, 2011

Alabama Dermatology Society, Sinai Conference, New York

October, 2010, 2014

ASDS Annual Meeting Faculty and nationally recognized speaker

April, 2011

ASLMS

June, 2012-2015

Vegas Cosmetic Surgery Symposium- Guest Faculty Speaker and Panelist

"Adult Females with Acne"
"Choosing Your Palette: Which Neurotoxins, Fillers, and Volumizers to Use in Which Patients and Why"
"My Pleasure… Said with a Smile: Improving Customer Service"
"Office Meetings: When? How Often? Are They Important?"
"Dealing with Bad Employees, Hiring Strategies, and Incentive Programs"
"How to Plan the Best Office Events"
"What's on your Bathroom Sink and Why"
"How to Get the Most for Your Marketing Buck"
"Cosmeceuticals: Latest and Greatest"

State licensure & certification

Medical License: South Carolina
Current BLS, ACLS
Current DEA Registration

Published articles & research studies

"Observational Post-Marketing Safety Surveillance Registry of Enbrel® (Etanercept) for the Treatment of Psoriasis" (OBSERVE-5), Completed 2013 March.

"Tightening the envelop': ultrasound-based tightening and lifting" Practical Dermatology. 2012 April; 36-37.

"Understanding the liposcupting spectrum from surgery to cryolipolysis." Practical Dermatology. 2011 April;53-57.

"Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone 5% gel in combination with tazarotene 0.1% cream in patients with acne vulgaris." Journal of Drugs in Dermatology (JDD). 2010 July.

"Does imiquimod histologically rejuvenate ultraviolet radiation-damaged skin?" American Society of Dermatologic Surgery 2007 Sep.

"Topical 5% imiquimod for the therapy of actinic cheilitis." J Am Acad Dermatol 2002 Oct.: 47(4);497-501

"Therapy of Bowen's disease in transplant patients with imiquimod and 5% 5FU" Dermatol Surg. 2001 Jun; 27(6);561-4.

"CD34 + Cellular Blue Nevi" J Cutan Path. 2001 Mar; 28(3);145-50.

"Treatment of Bowen's disease in immune suppressed patients with imiquimod and COX inhibitors: Dermatol Surg. 2001 Feb; 27(2):143-6.

"Smoldering HTLV- I -induced T-cell lymphoma localized within the skin; a radiation-resistant tumor" Int J Dermatol. 2000 Nov; 39(11):815-2 1.

"The cutaneous cellular infiltrate to stingray envenomization contains increased TIA + cells" Br J Dermatol.2000 Nov; 143(5):1074-7.

"Telomerase: carcinogenesis and aging, Part 11" Cosmetic Dermatology. 2000 Feb.

"Telomerase: carcinogenesis and aging, Part I" Cosmetic Dermatology. 2000 Jan.

"Perspectives in Dermatolpathology: telomeres and telomerase in aging and cancer; with emphasis on cutaneous disease" J Cutan Path. 2000 Jan; 27(l): 2-18. Review.

"Increased soft tissue in the posterior' cervical and upper back area of patients on HIV- I protease inhibitors" J Cutan Med Surg. 1999 Apr: 3(4).211- 7.